볼리션알엑스 (VNRX) 주가

볼리션알엑스(VNRX)는 NYSE MKT에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.54 (-14.78%), 시가총액 $0.02B, 52주 범위 $0.14 ~ $2.78.

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for earl

핵심 지표

• 현재가: $0.54 (-14.78%)
• 시가총액: $0.02B
• 52주 최저~최고: $0.14 ~ $2.78
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE MKT

볼리션알엑스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

볼리션알엑스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.3333

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 38.44
• 순이익률: 0.00%
• 영업이익률: -10.78%

자주 묻는 질문